Bharat Seats Limited has submitted a regulatory disclosure pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled for Tuesday, October 27, 2026, to consider and approve the unaudited financial results for the quarter and six months ended September 30, 2026 (Q2 FY27 and H1 FY27).
The company had previously informed about trading window closure via letter dated September 28, 2026. As per the Company's Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed until 48 hours after the financial results are submitted to the stock exchanges.
The disclosure was signed by Ritu Bakshi, Company Secretary and Compliance Officer (Membership No.: F3401), on October 21, 2026, at 14:47:44 IST.
Financial Impact
Financial results not yet disclosed - awaiting board approval on October 27, 2026.